Related Experiment Video

Updated: Dec 10, 2025

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.2K

Precision Medicine Stumbles in Umbrella Trial

    Cancer Discovery
    |August 29, 2020
    PubMed

    Insights

    The National Lung Matrix Trial found targeted therapies for non-small cell lung cancer had limited success. New strategies are needed to improve precision medicine effectiveness.

    Area of Science:

    • Oncology
    • Genomics
    • Clinical Trials

    Background:

    • The National Lung Matrix Trial investigated targeted therapies for non-small cell lung cancer (NSCLC).
    • The trial focused on drug efficacy based on specific genomic aberrations in NSCLC patients.

    Discussion:

    • Most targeted drugs showed limited efficacy despite being prescribed for specific genomic alterations.
    • This highlights challenges in current precision medicine approaches for NSCLC.

    Key Insights:

    • Genomic-guided targeted therapy demonstrated low efficacy in a large NSCLC trial.
    • Patient response did not consistently correlate with identified genomic aberrations.

    Outlook:

    • Further research is essential to refine precision medicine strategies in NSCLC.
    • Novel therapeutic approaches are required to overcome treatment resistance and improve patient outcomes.

    More Related Videos

    Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis07:40

    Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

    Published on: March 20, 2021

    18.0K
    Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer07:59

    Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

    Published on: September 8, 2023

    1.5K

    Related Concept Videos

    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
    5.7K